Research Articles
When Cancer Treatment Surprises the Brain: The Unusual Case of Chemoembolization-Linked PRES
Exploring the paradoxical connection between targeted liver cancer treatment and unexpected neurological complications through posterior reversible encephalopathy syndrome (PRES).
The Force Within: How Cells Feel and Respond to Their Physical World
Explore the fascinating world of mechanobiology and how cells sense and respond to physical forces in their environment.
Cracking Cancer's Code: Tracking a Smart Bomb Inside a Cell
Discover how scientists use orthogonal double-click chemistry to track platinum-based anticancer agents inside cancer cells, revolutionizing targeted cancer treatment.
The Triazine Scaffold: Chemistry's Versatile Architect in Modern Medicine
Explore the remarkable triazine scaffold - a versatile molecular structure revolutionizing drug development for cancer, infectious diseases, and neurological disorders.
Monoclonal Antibodies: The Guided Missiles Revolutionizing Cancer Treatment
How lab-made proteins became one of our most powerful weapons in the fight against cancer. Explore the science, history, and future of monoclonal antibody therapy.
Beyond Mitosis: The Surprising Story of Mad1 in Cell Migration and Cancer
Discover how Mad1, a mitotic checkpoint protein, controls integrin secretion and cell migration with implications for cancer progression.
Beyond the Glass: How Wine Flavonoids Power Your Health and Slow Aging
Discover the science behind wine flavonoids and their remarkable health benefits for cardiovascular health, brain function, and healthy aging.
Beyond Hydroxamates: The New Frontier of HDAC6 Inhibitors
Explore the latest advances in non-hydroxamate HDAC6 inhibitors, their medicinal chemistry, and therapeutic potential for cancer and neurodegenerative diseases.
The Unseen Legacy: How Manhattan Project Waste Still Affects Health Today
Exploring the lasting health impacts of Manhattan Project radioactive waste through epidemiological studies and modern research findings.
BAY 1816032: A New Ally in the Fight Against Cancer
Explore BAY 1816032, a novel BUB1 kinase inhibitor with potent antitumor activity that enhances cancer treatment effectiveness.